Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice
about
Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neuronsPhosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical ImplicationsMorris water maze: procedures for assessing spatial and related forms of learning and memoryEffect of chronic glutathione deficiency on the behavioral phenotype of Gclm-/- knockout mice.Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiencyPredictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia.cGMP Signaling, Phosphodiesterases and Major Depressive Disorder.RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.Emerging treatments for narcolepsy and its related disorders.Phosphodiesterase-1b deletion confers depression-like behavioral resistance separate from stress-related effects in mice.Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.PDE Inhibitors for the Treatment of Schizophrenia.Phosphodiesterase-1b (Pde1b) knockout mice are resistant to forced swim and tail suspension induced immobility and show upregulation of Pde10a.Recent advances in the treatment of narcolepsy.
P2860
Q21131062-E4E49289-0C63-4E9C-81E5-CB5B96FF5330Q24633622-A09264D1-6484-4721-A90B-A9FD9311C7CBQ26753116-948B75D5-A241-4DD6-AD71-FBC2B3935EDEQ28296351-7728C5A9-84EB-4234-8F7F-22BD9D76103DQ30453031-01F9C5DB-AA85-458F-ACF1-335E973CF4B3Q30477551-64301B96-0D77-4172-88B9-AC0A8820A4C2Q34125605-2F733C9F-7467-4C32-A495-669D3A174236Q35687052-CB87BBF5-6ABE-4469-8D9B-6F1EFFF71F16Q37482165-303EBB0B-31D7-44D6-A340-C660221665DDQ37694570-445183A6-E04F-4EF1-ACC1-AA3BCBE16C20Q38794842-16E993D4-387A-4444-93F9-B93203B5889AQ39067400-BB948896-8D0C-46C2-A1C0-52628AC973EFQ39072124-77971B34-F51D-4340-A8BC-F210FEDA4B69Q42515895-F318F990-1B5E-47CF-845C-0097CDAC00F8Q47611419-290F6559-4460-4D9D-9C5E-0D5CC40A78D6Q47936368-7945BBC7-E160-40C3-89B2-A011DA9C62FFQ48293539-D1F6550C-C914-48FF-8E70-4A1AA2E067FF
P2860
Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice
description
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Oktober 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/10/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/10/01)
@nl
наукова стаття, опублікована в жовтні 2006
@uk
مقالة علمية (نشرت في أكتوبر 2006)
@ar
name
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@ast
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@en
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@nl
type
label
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@ast
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@en
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@nl
prefLabel
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@ast
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@en
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@nl
P2093
P2860
P921
P3181
P1476
Phosphodiesterase 1B different ...... B-DARPP32 double-knockout mice
@en
P2093
A. A. Fienberg
C. V. Vorhees
G. A. Gudelsky
L. A. Ehrman
M. T. Williams
T. L. Schaefer
T. M. Reed
P2860
P304
P3181
P356
10.1111/J.1601-183X.2006.00209.X
P407
P577
2006-10-01T00:00:00Z